Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms

Published:2013-10-22 Issue:5 Volume:28 Page:1052-1059
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tenedini E, ,Bernardis I,Artusi V,Artuso L,Roncaglia E,Guglielmelli P,Pieri L,Bogani C,Biamonte F,Rotunno G,Mannarelli C,Bianchi E,Pancrazzi A,Fanelli T,Malagoli Tagliazucchi G,Ferrari S,Manfredini R,Vannucchi A M,Tagliafico E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013302.pdf

Reference43 articles.

1. Kralovics R, Teo SS, Buser AS, Brutsche M, Tiedt R, Tichelli A et al. Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood 2005; 106: 3374–3376.

2. Campbell PJ, Green AR . The myeloproliferative disorders. N Engl J Med 2006; 355: 2452–2466.

3. Milosevic JD, Kralovics R . Genetic and epigenetic alterations of myeloproliferative disorders. Int J Hematol 2013; 97: 183–197.

4. Levine RL, Pardanani A, Tefferi A, Gilliland DG . Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 2007; 7: 673–683.

5. Pardanani A, Laborde RR, Lasho TL, Finke C, Begna K, Al-Kali A et al. Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis. Leukemia 2013; 27: 1322–1327.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms;Leukemia;2024-08-23

2. Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases;Clinical and Experimental Medicine;2024-07-23

3. Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine;Cancers;2024-04-26

4. Clinical application of tumour-in-normal contamination assessment from whole genome sequencing;Nature Communications;2024-01-18

5. Genomic Stratification of Hematological Malignancies;HemaSphere;2023-05-25